Difference between revisions of "Mucinous carcinoma"
Jump to navigation
Jump to search
(+SO) |
m (→Sign out) |
||
| Line 65: | Line 65: | ||
NEGATIVE: CK7. | NEGATIVE: CK7. | ||
The immunostains are suggestive of a lower gastrointestinal tract primary | The immunostains are suggestive of a lower gastrointestinal tract primary. Radiologic | ||
and endoscopic correlation is suggested. | |||
is suggested. | |||
</pre> | </pre> | ||
Revision as of 15:25, 10 April 2013
Mucinous carcinoma, also mucinous adenocarcinoma, is an epithelial neoplasm that produces mucin. Mucinous carcinoma can arise in a number of sites.
General
Prognostic significance dependent on the primary site:
- Breast mucinous carcinoma has a better prognosis.
- Colorectal mucinous carcinoma has a worse prognosis.[1]
Specific sites
Gross
- Gelatinous-like material.
- May have a consistency similar to Jello.
Image:
- Mucinous adenocarcinoma of the lung (flickr.com).
- Ovarian mucinous cystadenocarcinoma (flickr.com/euthman).
Microscopic
Features:
- Mucin - amphormous whispy or cream material.
- Cytologically atypical cells within the mucin.
- +/-Tumour without mucin.
- Maximum amount acceptable depends on the primary site (see proportion of mucin section below).
Note:
- Mucin alone -- should prompt a search for atypical cells, i.e. levels should be done.
DDx:
- Benign mucocele.
- Mucin extravasation - no malignant cells present.
- Adenoma with pseudoinvasion (pseudocarcinoma).[2]
- Adenocarcinoma with mucinous features - see proportion of mucin section.
Images:
- Colonic mucinous adenocarcinoma - low mag. (WC).
- Mucinous tumours of the ovary - several images (flickr.com).
Proportion of mucin
The criteria for diagnosing "mucinous carcinoma" varies by the anatomical site:
- Mucinous prostate carcinoma: > 25% of the tumour.[3]
- Mucinous colorectal carcinoma: > 50% of the tumour.[4]
- Mucinous gastric carcinoma: > 50% of the tumour.
- Mucinous breast carcinoma: > 90% of the tumour.[5]
- One source suggests: > 50% of the tumour.[6]
IHC
Can be used to suggest a primary site:[7]
- Upper GI tract: CK7 +ve (38/41 cases), CDX2 -ve (4 +ve/41 cases).
- Lower GI tract: CDX2 +ve (42/42 cases), CK20 +ve (41/42 cases), CK7 -ve (8 +ve/42 cases) positive cases usu. in rectum/anus.
- Breast: CK7 +ve (18/18 cases), ER +ve (16/18 cases).
- Lung: CK7 +ve (16/16 cases).
- Gynecologic: CK7 +ve (25/27 cases).
Sign out
OMENTUM, CORE BIOPSY: - METASTATIC MUCINOUS ADENOCARCINOMA, SEE COMMENT. COMMENT: The tumour cells stain as follows: POSITIVE: CK20, CDX2. NEGATIVE: CK7. The immunostains are suggestive of a lower gastrointestinal tract primary. Radiologic and endoscopic correlation is suggested.
See also
References
- ↑ Hyngstrom, JR.; Hu, CY.; Xing, Y.; You, YN.; Feig, BW.; Skibber, JM.; Rodriguez-Bigas, MA.; Cormier, JN. et al. (Apr 2012). "Clinicopathology and Outcomes for Mucinous and Signet Ring Colorectal Adenocarcinoma: Analysis from the National Cancer Data Base.". Ann Surg Oncol. doi:10.1245/s10434-012-2321-7. PMID 22476818.
- ↑ Odze, Robert D.; Goldblum, John R. (2009). Surgical pathology of the GI tract, liver, biliary tract and pancreas (2nd ed.). Saunders. pp. 512. ISBN 978-1416040590.
- ↑ Grignon DJ (March 2004). "Unusual subtypes of prostate cancer". Mod. Pathol. 17 (3): 316–27. doi:10.1038/modpathol.3800052. PMID 14976541.
- ↑ Tozawa E, Ajioka Y, Watanabe H, et al. (2007). "Mucin expression, p53 overexpression, and peritumoral lymphocytic infiltration of advanced colorectal carcinoma with mucus component: is mucinous carcinoma a distinct histological entity?". Pathol. Res. Pract. 203 (8): 567–74. doi:10.1016/j.prp.2007.04.013. PMID 17679024.
- ↑ Dogan, E.; Aksoy, S.; Dizdar, O.; Arslan, C.; Dede, DS.; Ozisik, Y.; Altundag, K.. "Pure mucinous carcinoma of the breast: a single center experience.". J BUON 16 (3): 565-7. PMID 22006768.
- ↑ Park S, Koo J, Kim JH, Yang WI, Park BW, Lee KS (March 2010). "Clinicopathological characteristics of mucinous carcinoma of the breast in Korea: comparison with invasive ductal carcinoma-not otherwise specified". J. Korean Med. Sci. 25 (3): 361–8. doi:10.3346/jkms.2010.25.3.361. PMC 2826751. PMID 20191033. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2826751/.
- ↑ Chu, PG.; Chung, L.; Weiss, LM.; Lau, SK. (Dec 2011). "Determining the site of origin of mucinous adenocarcinoma: an immunohistochemical study of 175 cases.". Am J Surg Pathol 35 (12): 1830-6. doi:10.1097/PAS.0b013e3182299c25. PMID 21881489.